Coherus BioSciences Inc (NAS:CHRS)
$ 0.731 0.061 (9.1%) Market Cap: 84.22 Mil Enterprise Value: 187.79 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 39/100

Coherus BioSciences Inc at Cowen Healthcare Conference (Virtual) Transcript

Mar 01, 2021 / 09:00PM GMT
Release Date Price: $16.02 (-1.35%)
Kenneth Charles Cacciatore
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Wonderful. Thanks, everyone, for joining us. Thanks, Denny, for taking the time. It's great to see you. Looking forward next year to be able to see you in-person again back in Boston but a good substitute to have you here virtually.

So I'm joined by colleague, Georgi. Stacy, unfortunately, is at another meeting, so she couldn't join. But Georgi, Stacy and I can -- comprise our team.

So anyways, Denny, wonderful seeing you. It's been many years we've been working together. The story continues to evolve in really fascinating ways. I think my experience with you has been, you actually end up almost always universally doing what you say you're going to do. There's usually like in all things in drug development, it's not just up into the right. There's a little bit of pauses and moving around. But you eventually get exactly to where you plan on getting to. I think that's appropriate as we think about -- when we get into the PD-1 conversation and how you're going approach that market.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot